Abstract 11840: Serum Apolipoprotein E Levels Predict Residual Cardiovascular Risk in Patients With Chronic Coronary Syndrome Undergoing First Percutaneous Coronary Intervention and On-Statin Treatment

Tatsuya Fukase,Tomotaka Dohi,Ryota Nishio,Mitsuhiro Takeuchi,Norihito Takahashi,Yuichi Chikata,Hirohisa Endo,Shinichiro Doi,Hiroki Nishiyama,Iwao Okai,Hiroshi Iwata,Shinya Okazaki,Kikuo Isoda,Katsumi Miyauchi,Hiroyuki Daida,Tohru Minamino

Abstract 11840: Serum Apolipoprotein E Levels Predict Residual Cardiovascular Risk in Patients With Chronic Coronary Syndrome Undergoing First Percutaneous Coronary Intervention and On-Statin Treatment

2021

Tatsuya Fukase
Tomotaka Dohi
Ryota Nishio
Mitsuhiro Takeuchi
Norihito Takahashi
Yuichi Chikata
Hirohisa Endo
Shinichiro Doi
Hiroki Nishiyama
Iwao Okai
Hiroshi Iwata
Shinya Okazaki
Kikuo Isoda
Katsumi Miyauchi
Hiroyuki Daida
Tohru Minamino

Background: Little is known about the long-term impact of apolipoprotein E (apoE) on residual cardiovascular risk in the patients with chronic coronary syndrome (CCS) receiving statin treatment. Me...

Keywords:

Cardiology
Percutaneous coronary intervention
Apolipoprotein E
statin treatment
Internal medicine
Medicine
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations